Glaxosmithkline Share News (GSK)

UK Dividends Calendar - Week Ahead

Ex-divs to take 10.73 points off FTSE 100 on Feb. 19

LONDON, Feb 16 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-make

UK Dividends Calendar - Week Ahead

London close: FTSE closing in on record high as commodity stocks rally

UK stocks jumped on Friday as rising commodity prices lifted shares in the oil and mining sectors, while hopes increased that Europe can come to an agreement over the future of Greece. The FTSE 100 rose 0.7% to 6,873.52 by the end of trade, its best finish since early September 2014. The index is no

UK Dividends Calendar - Week Ahead

FTSE 100 movers: Glaxosmithkline upgraded, miners and oil stocks higher

Glaxosmithkline's shares were given a boost by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point" after a tough few years. The bank hiked its target price for the stock from 1,250p to 1,700p. The sh

BUZZ-GlaxoSmithKline Plc: UBS upgrades to "buy"

** UK-based drugmaker's shares up 4.4 pct at 1,550.5 pence on the London Stock Exchange; stock top gainer on FTSE 100 ** U.S.-listed shares up 4 at $47.61 premarket ** UBS raises its rating to "buy" from "sell", saying it expects new products sees strong growth. Also raises price tar

Broker tips: Glaxosmithkline, Rolls-Royce, ITV

Glaxosmithkline's shares were given a boost on Friday by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point". The bank hiked its target price for the stock from 1,250p to 1,700p, saying it foresees p

London midday: Eurozone GDP data lifts markets as resource stocks rise

Stronger-than-expected Eurozone growth figures and easing concerns about Ukraine and Greece gave stocks a boost in London on Friday, with resource shares leading the advance. The FTSE 100 was trading 0.6% higher at 6,869 by midday, as metal and oil stocks tracked commodity prices higher. Eurozone g

UK WINNERS & LOSERS: Oil Producers Benefit As Brent Surpasses USD60

Glaxosmithkline at "inflection point" as UBS upgrades from 'sell' to 'buy'

Glaxosmithkline's shares were given a boost on Friday by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point". The bank hiked its target price for the stock from 1,250p to 1,700p, saying it foresees s

UK BROKER RATINGS: UBS Upgrades GlaxoSmithKline To Buy From Sell

UK MORNING BRIEFING: Oil Shares Lead London Higher As Brent Tops USD60

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead